Vicriviroc Maleate
CAS: 599179-03-0
Rif. TR-V250000
10mg | Fuori produzione | ||
50mg | Fuori produzione | ||
2500µg | Fuori produzione |
Informazioni sul prodotto
- 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methyl-piperidine (2Z)-2-butenedioate (1:1)
- (4,6-Dimethylpyrimidin-5-yl){4-[(3S)-4-{(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl}-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}methanone (2Z)-but-2-enedioate (1:1)
- methanone, (4,6-dimethyl-5-pyrimidinyl)[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methyl-1-piperidinyl]-, (2Z)-2-butenedioate (1:1)
- Vicriviroc maleate
- 1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]-4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methylpiperidine (2Z)-2-butenedioate
Applications Vicriviroc Maleate, is a potent antagonist of CCR5, a G-protein coupled receptor.
References Alonzo III, F., et al.: Nature, 493, 51 (2013); Velasco-Velázquez, M., et al.: Cancer Res., 72, 3839 (2012); Kamp, C., et al.: Virol. J., 7, 55 (2010); Symons, J., et al.: J. Antimicrob. Chemother., 66, 890 (2011)